- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
OneSource, with Hikma, secured approval for generic Ozempic® (semaglutide) in Saudi Arabia. This partnership enables commercialization in a key GLP-1 market, aiming to increase access to high-quality, affordable therapy.